Wednesday, November 14, 2012

Investopedia: Time For Hologic To Translate Technology Into Results

How does an investor profit if a company has the best technology in the world, but can't deliver market-beating returns? That's probably a harsh intro for Hologic (Nasdaq:HOLX) today, but the fact remains that the company has to demonstrate that it can drive tomosynthesis adoption and solid growth in diagnostics for this stock to really work over the coming years. That puts the shares in a challenging place for investors; bulls can likely see a lot of value here, while bears will point to the high debt and oncoming competition and likely conclude that the shares are best avoided for now.

Please click the link to continue:
http://www.investopedia.com/stock-analysis/2012/Time-For-Hologic-To-Translate-Technology-Into-Results-HOLX-GE-CPHD-BDX1114.aspx

No comments: